Escitalopram in Adult Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00668525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Fixed-dose Study of Escitalopram in Adult Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression. Patients completing the study may be eligible to enter a long-term open-label extension study with escitalopram.
Study identification
- NCT ID
- NCT00668525
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 877 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Feb 2009 (Actual)
- Completion
- Not listed
- Last update posted
- May 11, 2010
Started 2008
United States locations
- U.S. sites
- 45
- U.S. states
- 23
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Phoenix | Arizona | 85016 | — |
| Forest Investigative Site | Arcadia | California | 91007 | — |
| Forest Investigative Site | Encino | California | 91316 | — |
| Forest Investigative Site | Garden Grove | California | 92845 | — |
| Forest Investigative Site | Irvine | California | 92618 | — |
| Forest Investigative Site | Los Alamitos | California | 90720 | — |
| Forest Investigative Site | Denver | Colorado | 80212 | — |
| Forest Investigative Site | Washington D.C. | District of Columbia | 20016 | — |
| Forest Investigative Site | Bradenton | Florida | 34208 | — |
| Forest Investigative Site | Jacksonville | Florida | 32216 | — |
| Forest Investigative Site | Orlando | Florida | 32806 | — |
| Forest Investigative Site | West Palm Beach | Florida | 33407 | — |
| Forest Investigative Site | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site | Newton | Kansas | 67114 | — |
| Forest Investigative Site | Overland | Kansas | 66221 | — |
| Forest Investigative Site | Baltimore | Maryland | 21208 | — |
| Forest Investigative Site | Glen Burnie | Maryland | 21061 | — |
| Forest Investigative Site | Rockville | Maryland | 20852 | — |
| Forest Investigative Site | Okemos | Michigan | 48864 | — |
| Forest Investigative Site | St Louis | Missouri | 63044 | — |
| Forest Investigative Site | Omaha | Nebraska | 68131 | — |
| Forest Investigative Site | Omaha | Nebraska | 68198 | — |
| Forest Investigative Site | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site | Clementon | New Jersey | 08021 | — |
| Forest Investigative Site | Brooklyn | New York | 11235 | — |
| Forest Investigative Site | New York | New York | 10021 | — |
| Forest Investigative Site | New York | New York | 10024 | — |
| Forest Investigative Site | Staten Island | New York | 10312 | — |
| Forest Investigative Site | The Bronx | New York | 10467 | — |
| Forest Investigative Site | Canton | Ohio | 44708 | — |
| Forest Investigative Site | Dayton | Ohio | 45408 | — |
| Forest Investigative Site | Portland | Oregon | 97210 | — |
| Forest Investigative Site | Media | Pennsylvania | 19063 | — |
| Forest Investigative Site | Philadelphia | Pennsylvania | 19107 | — |
| Forest Investigative Site | Charleston | South Carolina | 29405 | — |
| Forest Investigative Site | Memphis | Tennessee | 38117 | — |
| Forest Investigative Site | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site | Austin | Texas | 78756 | — |
| Forest Investigative Site | Houston | Texas | 77008 | — |
| Forest Investigative Site | San Antonio | Texas | 78229 | — |
| Forest Investigative Site | Salt Lake City | Utah | 84107 | — |
| Forest Investigative Site | Woodstock | Vermont | 05091 | — |
| Forest Investigative Site | Richmond | Virginia | 23230 | — |
| Forest Investigative Site | Bellevue | Washington | 98004 | — |
| Forest Investigative Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00668525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2010 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00668525 live on ClinicalTrials.gov.